Insider · CIK 0001841637
Gael Forterre
Files at VNRX (VOLITIONRX LTD). First filing -, latest -.
Gael Forterre files SEC Form 4 as officer at VNRX (VOLITIONRX LTD). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Gael Forterre has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 17 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 28, 2026 | VNRX VOLITIONRX LTD | FTax withholding Common Stock | -284 | $0.25 | $72 | 16,284 | 13 d ago |
| Mar 17, 2026 | VNRX VOLITIONRX LTD | FTax withholding Common Stock | -5,251 | $0.19 | $998 | 331,338 | Mar 19, 2026 |
| Mar 1, 2026 | VNRX VOLITIONRX LTD | FTax withholding Common Stock | -2,283 | $0.21 | $486 | 336,589 | Mar 3, 2026 |
| Feb 26, 2026 | VNRX VOLITIONRX LTD | AGrant or award Common Stock | +149,000 | $0.00 | $0 | 338,872 | Feb 27, 2026 |
| Feb 1, 2026 | VNRX VOLITIONRX LTD | FTax withholding Common Stock | -2,010 | $0.29 | $573 | 189,872 | Feb 3, 2026 |
| Jan 22, 2026 | VNRX VOLITIONRX LTD | AGrant or award Common Stock | +38,100 | $0.00 | $0 | 191,882 | Jan 23, 2026 |
| Nov 1, 2025 | VNRX VOLITIONRX LTD | FTax withholding Common Stock | -1,753 | $0.43 | $761 | 153,782 | Nov 4, 2025 |
| Oct 4, 2025 | VNRX VOLITIONRX LTD | FTax withholding Common Stock | -5,389 | $0.65 | $3,492 | 155,535 | Oct 7, 2025 |
| Sep 28, 2025 | VNRX VOLITIONRX LTD | FTax withholding Common Stock | -5,503 | $0.61 | $3,329 | 160,924 | Sep 30, 2025 |
| Aug 15, 2025 | VNRX VOLITIONRX LTD | AGrant or award Common Stock | +9,727 | $0.00 | $0 | 166,427 | Aug 19, 2025 |
| Aug 1, 2025 | VNRX VOLITIONRX LTD | FTax withholding Common Stock | -2,766 | $0.64 | $1,770 | 156,700 | Aug 5, 2025 |
| Jun 1, 2025 | VNRX VOLITIONRX LTD | FTax withholding Common Stock | -1,996 | $0.77 | $1,533 | 159,466 | Jul 3, 2025 |
| Jun 1, 2025 | VNRX VOLITIONRX LTD | AGrant or award Common Stock | +6,690 | $0.00 | $0 | 165,696 | Jun 3, 2025 |
| Jun 1, 2025 | VNRX VOLITIONRX LTD | FTax withholding Common Stock | -4,234 | $0.50 | $2,130 | 161,462 | Jun 3, 2025 |
| May 1, 2025 | VNRX VOLITIONRX LTD | FTax withholding Common Stock | -3,698 | $0.49 | $1,803 | 159,006 | May 5, 2025 |
| Mar 1, 2025 | VNRX VOLITIONRX LTD | AGrant or award Common Stock | +5,523 | $0.00 | $0 | 162,704 | Mar 4, 2025 |
| Dec 1, 2024 | VNRX VOLITIONRX LTD | AGrant or award Common Stock | +4,828 | $0.00 | $0 | 157,181 | Dec 3, 2024 |
Questions about Gael Forterre
Answered from the filings on this page, as of the latest one.
Is Gael Forterre buying or selling?
Gael Forterre has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Gael Forterre's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Gael Forterre has 0.
Where does Gael Forterre file Form 4?
Gael Forterre has filed Form 4 at VNRX (VOLITIONRX LTD) as Chief Commercial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.